Spectrum Asset Management, Inc. Gilead Sciences, Inc. Transaction History

Spectrum Asset Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 22, 2020	SELL	$72.34 - $84.0 $2.41 Million - $2.8 Million	-33,361 Closed	0 $0
Q1 2020 Apr 22, 2020	BUY	$62.63 - $80.22 $26,930 - $34,494	430 Added 1.31%	33,361 $2.49 Million
Q4 2019 Feb 07, 2020	BUY	$61.62 - $67.78 $259,112 - $285,014	4,205 Added 14.64%	32,931 $2.14 Million
Q3 2019 Oct 24, 2019	BUY	$62.51 - $69.0 $37,943 - $41,883	607 Added 2.16%	28,726 $1.82 Million
Q1 2019 Apr 16, 2019	BUY	$62.53 - $70.05 $195,093 - $218,556	3,120 Added 12.48%	28,119 $1.83 Million
Q4 2018 Jan 28, 2019	SELL	$60.54 - $79.0 $18,162 - $23,700	-300 Reduced 1.19%	24,999 $1.56 Million
Q3 2018 Oct 29, 2018	BUY	$71.28 - $78.92 $1.6 Million - $1.77 Million	22,475 Added 795.86%	25,299 $1.95 Million
Q1 2018 May 04, 2018	SELL	$72.84 - $88.8 $43,704 - $53,280	-600 Reduced 17.52%	2,824 $204,000
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $30,167 - $35,412	424 Added 14.13%	3,424 $245,000
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $216,330 - $256,410	3,000	3,000 $243,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Spectrum Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Spectrum Asset Management, Inc. with notifications on news.